Skip to main content
Search
News, Views, and Advocacy From the Oncology Nursing Society
ONS Voice Home
  • News & Views
  • Advocacy
  • Stories
  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
    • News & Views
    • Latest Articles
    • Clinical Practice
    • ONS News
    • ONS Leadership
    Trending Topics
    • Treatments
    • Research
    • Safety
    • ONS Congress
    • Clinical practice
    • U.S. Food and Drug Administration (FDA)
    View All Topics
    Advocacy
    • Latest Articles
    • Updates
    • Get Involved
    Stories View All
    View All
    Advocacy Grows Through Personality as Well as Profession
    Health Policy
    Advocacy Grows Through Personality as Well as Profession
    June 13, 2019
    Advocate in Your Own Backyard
    Cancer healthcare advocacy
    Advocate in Your Own Backyard
    May 09, 2019
    Health Policy Begins With You: Educate Your Representatives in Cancer Care
    Health Policy
    Health Policy Begins With You: Educate Your Representatives in Cancer Care
    April 04, 2019
    Providing Expert Testimony in the Virginia State Senate
    Cancer healthcare advocacy
    Providing Expert Testimony in the Virginia State Senate
    March 14, 2019
    Summer Oncology Nursing Fellowship Program Supports Undergraduate Students
    Oncology nursing community
    Summer Oncology Nursing Fellowship Program Supports Undergraduate Students
    February 22, 2019
    previous slide
    next slide
    Search
  • News & Views
  • Advocacy
  • Stories
    • Home

    Author Content

    FDA Links Breast Implants to Increased ALCL Risk
    U.S. Food and Drug Administration (FDA)

    FDA Links Breast Implants to Increased ALCL Risk

    People with breast implants have a risk of developing breast implant-associated anaplastic large cell lymphoma (ALCL), the U.S. Food and Drug Administration (FDA) announced in April 2019. Typically the cancer is limited to the scar tissue and fluid near an implant, but some patients experience spread throughout the body. The risk increases with textured implants in particular.

    June 12, 2019
    Survivorship Considerations After CAR T-Cell Therapy
    Immunotherapy

    Survivorship Considerations After CAR T-Cell Therapy

    As more patients receive treatment with chimeric antigen receptor (CAR) T-cell therapy, oncology nurses will need to be aware of the long-term effects of treatment that may persist into survivorship. However, because the treatment is so new, studies measuring those patient-reported concerns are still forthcoming. The majority of today’s recommendations for survivorship management are based on experts’ clinical experience.

    June 11, 2019
    Less Toxic CAR T-Cell Therapy May Be on the Horizon
    Treatments

    Less Toxic CAR T-Cell Therapy May Be on the Horizon

    Preliminary results reported in Nature Medicine showed that a redesigned CAR T-cell therapy produced complete response with no severe toxicities in 25 patients with refractory B-cell lymphoma.

    June 05, 2019
    FDA Cautions That Robotic Devices Are Not Approved for Mastectomy or Other Women’s Cancer Surgeries
    U.S. Food and Drug Administration (FDA)

    FDA Cautions That Robotic Devices Are Not Approved for Mastectomy or Other Women’s Cancer Surgeries

    Because of limited preliminary evidence that the use of robotic-assisted surgical devices for treatment or prevention of women’s cancers may be associated with diminished long-term survival, the U.S. Food and Drug Administration (FDA) issued a reminder warning to healthcare providers and the public in February 2019 that the technique has not been FDA approved for this purpose.

    May 22, 2019
    Commission on Cancer to Revise Standards for Cancer Program Accreditation
    Standards

    Commission on Cancer to Revise Standards for Cancer Program Accreditation

    The Commission on Cancer (CoC), an organizational consortium of which ONS is a governing member, provides standards for cancer programs to follow to achieve a high level of continuous quality improvement. Last updated in 2016, the standards are currently undergoing analysis and revision, and CoC is seeking public comments until June 3, 2019.

    May 20, 2019
    Gut Microbiome Diversity May Improve Response to Melanoma Immunotherapy
    Research

    Gut Microbiome Diversity May Improve Response to Melanoma Immunotherapy

    A high-fiber diet leading to higher gut microbiome diversity may improve response to anti-PD-1 immunotherapy in patients with melanoma, according to the results of a new study presented at the 2019 American Association for Cancer Research Annual Meeting in Atlanta, GA. 

    May 15, 2019
    Liquid Biopsy Equivalent to Tissue for NSCLC
    Lung Cancer

    Liquid Biopsy Equivalent to Tissue for NSCLC

    With faster and equally accurate results, liquid biopsy may be an option for identifying guideline-recommended targeted therapies for non-small cell lung cancer (NSCLC), according to findings presented at the 2019 American Association for Cancer Research Annual Meeting in Atlanta, GA. 

    May 08, 2019
    New Genetics Service Delivery Models Help Patients Access Genetic Counseling
    Genetics & genomics

    New Genetics Service Delivery Models Help Patients Access Genetic Counseling

    As genetic and genomic testing become more common—and complex—in cancer diagnosis and treatment decisions, more efficient and accessible ways of providing comprehensive genetic care are needed. In their article in the February 2019 issue of the Clinical Journal of Oncology Nursing, Pierle and Mahon discussed the findings from their literature review, specifically pertaining to genetics care services across the cancer continuum, patient and system barriers to accessing care, new service delivery models, and oncology nurses’ role in providing comprehensive cancer genetics care services.

    May 07, 2019
    Kentucky Illustrates Success of Medicaid Expansion
    Medical reimbursement

    Kentucky Illustrates Success of Medicaid Expansion

    The state of Kentucky has seen some of the most success in reducing its uninsured rate thanks to the Affordable Care Act’s Medicaid expansion that took effect on January 1, 2014. The results of a new study, published in the Journal of the American College of Surgeons, showed that as the number of insured individuals rose, so too did important cancer screening rates.

    May 01, 2019
    Updated Scope and Standards Represent Key Foci of Oncology Nursing Practice
    Clinical practice

    Updated Scope and Standards Represent Key Foci of Oncology Nursing Practice

    To ensure that the Oncology Nursing: Scope and Standards of Practice are consistent with overall nursing standards and to increase the visibility of the oncology nursing standards in the greater nursing and healthcare communities, ONS released an updated version of its reference book in March 2019. The American Nurses Association (ANA) recognizes oncology nursing as a nursing specialty, and the new edition carries ANA’s approval of the oncology nursing scope of practice and acknowledgement of the oncology nursing standards of practice.

    April 26, 2019
    Tachycardia Tied to Higher Mortality in Patients With Cancer
    Symptom management

    Tachycardia Tied to Higher Mortality in Patients With Cancer

    Rates of all-cause mortality in patients with cancer increase in the presence of unexplained sinus tachycardia, the results of a new study show. Researchers presented the findings at the Advancing Cardiovascular Care of the Oncology Patient conference held January 2019 in Washington, DC.

    April 24, 2019
    Guidelines Insufficient for Prostate Cancer Germline Genetic Testing
    Research

    Guidelines Insufficient for Prostate Cancer Germline Genetic Testing

    According to researchers, only 43.8% of positive genetic variants detected in men with prostate cancer had corresponding recommendations for germline testing in National Comprehensive Cancer Network (NCCN) guidelines. The findings were published in JAMA Oncology.

    April 17, 2019
    Microfluidic Device May Pave Way for More Liquid Cancer Biopsies
    Targeted therapy

    Microfluidic Device May Pave Way for More Liquid Cancer Biopsies

    Researchers have developed a device that can separate various cell types in patient blood samples based on the cell size, which may one day enable rapid, inexpensive liquid biopsies to help clinicians detect cancer and develop targeted treatment plans. Findings from the research that led to the device are reported in Microsystems and Nanoengineering.

    April 10, 2019
    For Oxaliplatin Hypersensitivity Reactions, Prevention Is the Best Strategy, but Here’s How to Manage Them
    Adverse events

    For Oxaliplatin Hypersensitivity Reactions, Prevention Is the Best Strategy, but Here’s How to Manage Them

    As the use of oxaliplatin in the treatment of gastrointestinal, gynecologic, and other cancers continues to grow, so too does the incidence of hypersensitivity reactions connected to the drug. Because the development of HSRs may require patients to discontinue oxaliplatin even if it’s effective against their cancer, oncology nurses need to be able to prevent or minimize reactions whenever possible.

    April 09, 2019
    ONS Hosts Inaugural International Oncology Nursing Conference in Azerbaijan
    ONS News

    ONS Hosts Inaugural International Oncology Nursing Conference in Azerbaijan

    Although cancer isn’t one of the very highest causes of death in Azerbaijan, the nation still feels the impact of the global cancer burden: lung cancer and gastrointestinal cancers rank number 8 and 10, respectively, on the top 10 causes of death in the country, and their incidence is growing. As part of its commitment to sustainable international programs to support the advancement of cancer care, ONS and its members have a responsibility to disseminate knowledge to international nurses in countries like Azerbaijan. 

    April 05, 2019
    Obesity-Related Cancer Incidence Increases in Young Adults
    Research

    Obesity-Related Cancer Incidence Increases in Young Adults

    A new study showed that incidence rates are increasing for 6 of the 12 obesity-related cancers in U.S. young adults and that, over time, the increases are occurring in progressively younger ages and successively younger generations. The findings were published in Lancet Public Health.

    April 03, 2019
    Smartphone App Helps Patients Manage Cancer Pain
    Pain management

    Smartphone App Helps Patients Manage Cancer Pain

    A smartphone app that monitors patients’ self-reported cancer pain and uses artificial intelligence (AI) to differentiate urgent and non-urgent issues and provide real-time recommendations significantly reduced pain and pain-related hospital admissions, researchers reported in an abstract presented at the November 2018 Palliative and Supportive Care in Oncology Symposium in San Diego, CA.

    March 27, 2019
    Ancestry Analysis Identifies Genetic Cause for Increased Multiple Myelmoma in African Americans
    Research

    Ancestry Analysis Identifies Genetic Cause for Increased Multiple Myeloma in African Americans

    Three cytogenetic subtypes are particularly responsible for the increased incidence of multiple myeloma in people of African descent, according to the results of a study published in Blood Cancer Journal.

    March 20, 2019
    Adding Chemo to Immunotherapy May Resensitize Resistant Tumors
    Immunotherapy

    Adding Chemo to Immunotherapy May Resensitize Resistant Tumors

    Using chemotherapy with immune checkpoint inhibitors may reactivate tumors’ responses to immunotherapy, researchers concluded in a review article published in the Annals of Oncology.

    March 13, 2019
    Understand the Evidence for Exercise in Gynecologic Cancer-Related Fatigue
    Treatment side effects

    Understand the Evidence for Exercise in Gynecologic Cancer-Related Fatigue

    Cervical cancer is the fourth most common cancer in women and the seventh most common overall. Cancer-related fatigue (CRF) has an estimated prevalence of 50%–90% in all patients and has been reported to affect 17%–33% of women with gynecologic cancers for as long as three to eight years after diagnosis. Many national guidelines from organizations such as the American College of Sports Medicine, American Cancer Society, National Institute for Health and Care Excellence, and ONS all recommend exercise to improve fatigue in patients with cancer. But no research has synthesized the evidence for exercise as an intervention for fatigue specifically in patients with gynecologic cancers. 

    March 12, 2019
    Hospital-Acquired Conditions Reduced by Nearly 1 Million From 2014–2017
    Clinical practice

    Hospital-Acquired Conditions Reduced by Nearly 1 Million From 2014–2017

    According to an Agency for Healthcare Research and Quality (AHRQ) analysis, the number of hospital-acquired conditions (HACs) reported in the United States dropped by 910,000 (13%) from 2014–2017. 

    March 06, 2019
    Open Hysterectomy Has Better Outcomes Than Minimally Invasive Surgery in Cervical Cancer
    Research

    Open Hysterectomy Has Better Outcomes Than Minimally Invasive Surgery in Cervical Cancer

    Women with early-stage cervical cancer have higher recurrence rates and worse overall survival with minimally invasive radical hysterectomy than abdominal radical hysterectomy, according to the results of two studies published in the New England Journal of Medicine.  

    February 27, 2019
    Modifying Five Lifestyle Factors Could Change the U.S. Cancer Burden
    Cancer risk prevention

    Modifying Five Lifestyle Factors Could Change the U.S. Cancer Burden

    Tobacco, obesity, alcohol, diet, and physical activity are major risk factors for cancer, yet all are modifiable, according to findings released in a new report from the American Cancer Society. Reducing tobacco use is the highest priority, but interventions for all five risk factors are essential for a comprehensive U.S. cancer control plan.

    February 26, 2019
    CMS Proposes Medicare Coverage for CAR T-Cell Therapy
    Immunotherapy

    CMS Proposes Medicare Coverage for CAR T-Cell Therapy

    To improve access to new cancer therapies and provide national consistency in coverage, on February 15, 2019, the Centers for Medicare and Medicaid Services (CMS) announced a proposed plan of coverage with evidence development for CAR T-cell therapy. The public is invited to share comments for the next 30 days.

    February 21, 2019
    Shorter EBRT for Early Prostate Cancer Has Similar Outcomes
    Prostate cancer

    Shorter EBRT for Early Prostate Cancer Has Similar Outcomes

    Patients receiving hypofractionated external-beam radiation therapy (EBRT) for early-stage prostate cancer experienced similar outcomes and toxicities as those receiving standard radiation at lower doses over a longer period of time, the American Society for Radiation Oncology, American Society of Clinical Oncology, and American Urological Association say in a new clinical guideline.

    February 20, 2019
    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9
    • Next page
    • Last page Last »
    picture of the author
    Elisa Becze BA, ELS, Editor
    Home
    News, Views, and Advocacy From the Oncology Nursing Society
  • Legal Notices
  • Contact Us
  • Conferences
  • Advertising
  • Newsroom
  • Sitemap

  • Instagram
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • RSS
  • ONS
  • Oncology Nursing Foundation
  • ONCC
    • © Copyright 2019 Oncology Nursing Society
    Back to Top ▲